Mira Pharmaceuticals Inc stock is traded at $0.6142, with a volume of 39,270. It is down -1.08% in the last 24 hours and down -17.61% over the past month. Mira Pharmaceuticals Inc is a clinical-stage pharmaceutical development company focused on developing novel oral small-molecule therapeutics for neurologic, neuropsychiatric, metabolic, and inflammatory disorders. The company's pipeline includes three product candidates: Ketamir-2, MIRA-55, and SKNY-1, three drug candidates designed to address unmet medical needs across neuropathic and inflammatory pain, central nervous system disorders, and metabolic and behavioral conditions. The company operates as a single operating and reportable segment.
Previous Close:
$0.6209
Open:
$0.62
24h Volume:
39,270
Relative Volume:
0.19
Market Cap:
$25.81M
Revenue:
-
Net Income/Loss:
-$31.37M
P/E Ratio:
-
EPS:
-$1.44
Net Cash Flow:
-$4.23M
1W Performance:
+9.48%
1M Performance:
-17.61%
6M Performance:
-37.96%
1Y Performance:
-57.64%
1-Day Range:
$0.6027$0.6275
1-Week Range:
$0.52$0.64
52-Week Range:
$0.51$1.69
Mira Pharmaceuticals Inc Stock (MIRA) Company Profile
Name
Mira Pharmaceuticals IncSector
HealthcareIndustry
Drug Manufacturers - GeneralPhone
813-369-5150Address
1200 BRICKELL AVENUE, MIAMI, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS